首页> 美国卫生研究院文献>Neuro-Oncology >Significance of targeted therapy and genetic alterations in EGFR ALK or KRAS on survival in patients with non–small cell lung cancer treated with radiotherapy for brain metastases

【2h】

Significance of targeted therapy and genetic alterations in EGFR ALK or KRAS on survival in patients with non–small cell lung cancer treated with radiotherapy for brain metastases

机译：EGFRALK或KRAS靶向治疗和基因改变对非小细胞肺癌脑转移放疗患者生存的意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundWe determined the impact of genetic alterations in EGFR, ALK, or KRAS on survival after radiotherapy for brain metastases in non–small cell lung cancer (NSCLC).

机译：背景我们确定了EGFR，ALK或KRAS基因改变对非小细胞肺癌（NSCLC）脑转移瘤放疗后生存的影响。

著录项

期刊名称 Neuro-Oncology
作者
Kimberley S. Mak; Justin F. Gainor; Andrzej Niemierko; Kevin S. Oh; Henning Willers; Noah C. Choi; Jay S. Loeffler; Lecia V. Sequist; Alice T. Shaw; Helen A. Shih;
展开▼
作者单位

展开▼
年(卷),期 2015(17),2
年度 2015
页码 296–302
总页数 7
原文格式 PDF
正文语种
中图分类神经病学;肿瘤学;
关键词
ALK brain metastases EGFR non–small cell lung cancer radiotherapy;

机译：ALK;脑转移瘤;EGFR;非小细胞肺癌;放疗;

相似文献

外文文献
中文文献
专利

1. Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases [J] . Kimberley S. Mak, Justin F. Gainor, Andrzej Niemierko, Neuro-Oncology . 2015,第2期

机译：EGFR，ALK或KRAS靶向治疗和基因改变对非小细胞肺癌脑转移放疗患者生存的意义
2. Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR , ALK and KRAS mutation status [J] . Oscar Arrieta, Laura‐Alejandra Ramírez‐Tirado, Enrique Caballé‐Perez, Thoracic cancer. . 2020,第4期

机译：根据EGFR，ALK和KRAS突变状态从最近诊断的非小细胞肺癌接受放射治疗的基线脑转移患者的反应率
3. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs [J] . Qi Gui, Jiangang Liu, Dapeng Li, World Journal of Surgical Oncology . 2017,第1期

机译：EGFR突变型TKIs手术切除脑和肺部病变后，EGFR突变的非小细胞肺癌伴单发脑转移的患者的生存期延长
4. Survival prediction using artificial neural networks in patients with lung cancer treated by radiotherapy [C] . Masahiro Iinuma, Teruki Teshima, Yuki Iwanaga, Internationao Congress and Exhibition . 2002

机译：放射治疗肺癌患者人工神经网络的生存预测
5. Developing Induced Neural Stem Cell Therapy to Treat Triple-Negative Breast Cancer and Brain Metastases [D] . Jiang, Wulin. 2021

机译：诱导神经干细胞疗法治疗三阴性乳腺癌和脑转移
6. Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR ALK and KRAS mutation status [O] . Oscar Arrieta, Laura‐Alejandra Ramírez‐Tirado, Enrique Caballé‐Perez, 2020

机译：根据EGFRALK和KRAS突变状态最近被诊断为非小细胞肺癌的放疗后基线脑转移患者的缓解率
7. Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR , ALK and KRAS mutation status [O] . Oscar Arrieta, Laura‐Alejandra Ramírez‐Tirado, Enrique Caballé‐Perez, 2020

机译：根据EGFR，ALK和KRAS突变状态从最近诊断的非小细胞肺癌接受放射治疗的基线脑转移患者的反应率

Significance of targeted therapy and genetic alterations in EGFR ALK or KRAS on survival in patients with non–small cell lung cancer treated with radiotherapy for brain metastases

摘要

著录项

相似文献

相关主题

期刊订阅